Head and neck squamous cell carcinoma targeted chemosensitization

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 2, 2009, Pages 177-183

  Figures, Mindy R ^a   Wobb, Jessie ^a   Araki, Koji ^a   Liu, Tingyan ^a,b   Xu, Lei ^a   Zhu, Hanjing ^a   O'Malley Jr , Bert W ^a   Li, Daqing ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CISPLATIN; FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN F(AB) FRAGMENT; MUTANT PROTEIN; RAD50 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CHEMOSENSITIZATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG CONJUGATION; DRUG CYTOTOXICITY; GENE EXPRESSION; GENE TRANSFER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SQUAMOUS CELL CARCINOMA; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; DISEASE MODELS, ANIMAL; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 67651021121     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.04.024     Document Type: Article

References (15)

1. Saito K., Khan K., Sosnowski B., et al. Cytotoxicity and antiangiogenesis by fibroblast growth factor 2-targeted Ad-Tk cancer gene therapy. Laryngoscope 119 (2009) 665-674
2. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 8 (2007) 573-584
3. Abuzeid W.M., Jiang X., Shi G., et al. Molecular disruption of Rad50 sensitizes tumor cells to cisplatin-based chemotherapy. J Clin Invest (2009) in press
4. Rodenburg C.J., and Cleton F.J. Chemotherapy in advanced ovarian cancer. J Cancer Res Clin Oncol 107 (1984) 99-105
5. Jacobs C., Lyman G., Velez-Garcia E., et al. A Phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10 (1992) 257-263
6. Vokes E.E., and Athanasiadis I. Chemotherapy of squamous cell carcinoma of head and neck: the future is now. Ann Oncol 7 (1996) 15-29
7. Tran H.M., SHI G., Li G., et al. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer. Otolaryngol Head Neck Surg 131 (2004) 477-484
8. Hopfner K.P., Putnam C.D., and Tainer J.A. DNA double-strand break repair from head to tail. Curr Opin Struct Biol 12 (2002) 115-122
9. Moon C., Oh Y., and Roth J.A. Current status of gene therapy for lung cancer and head and neck cancer. Clin Cancer Res 9 (2003) 5055-5067
10. Li D., Duan L., Freimuth P., et al. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 5 (1999) 4175-4181
11. Gao G.P., Yang Y., Wilson J.M., et al. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 70 (1996) 8934-8943
12. Presta M., Dell'Era P., Mitola S., et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16 (2005) 159-178
13. Dellacono F.R., Spiro J., Eisma R., et al. Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am J Surg 174 (1997) 540-544
14. Decatris M.P., Sundar S., and O'Byrne K.J. Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treat Rev 30 (2004) 53-81
15. Olive P.L., and Banath J.P. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1 (2006) 23-29